Oncofertility Survivorship Outcomes
Using Banked Sperm Years Later - Survival, Thaw Quality, ICSI Success and the Under-Referral Problem
Evidence grade 4 of 5, Strong. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Clinical practice (no single FDA product); endorsed by ASCO and ASRM fertility-preservation guidelines
Reference only. Not medical advice.
What can go wrong
The clinical risk is mostly a missed opportunity: time pressure before urgent chemotherapy, lack of referral systems, cost, and discomfort discussing fertility with young or very ill patients lead to under-banking that cannot be undone. Stored-sample non-use raises questions about counseling, ongoing storage fees, and disposition (including posthumous-use consent). Thaw survival varies by sample, but ICSI compensates for substantial loss.
This is something to take to a clinician. The Atlas can tell you what is known about oncofertility survivorship outcomes in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
This entry follows oncofertility forward in time - not the decision to bank, but what happens when survivors come back. Cryopreserved sperm banked before gonadotoxic treatment survives essentially indefinitely, and frozen-thawed sperm with ICSI achieves pregnancies comparable to fresh-sperm ICSI even after long storage. The persistent failure is upstream: many men, especially adolescents and the acutely ill, are never offered banking, and a large share of stored samples are ultimately never used.
Sperm banked before chemo can build a family a decade later - if the man was ever offered the chance.
What people take it for
What it is taken for. Approval, where it exists, covers only some of these.
How it works
Gonadotoxic chemotherapy (notably alkylating agents) and radiation damage the dividing spermatogonia, and recovery of spermatogenesis is variable and unpredictable - sometimes years, sometimes never. Banking before treatment captures sperm while still present. Because ICSI needs only a single viable sperm per egg, even a small thawed sample, or a low-quality survivor's recovered count, can produce a pregnancy, decoupling future fatherhood from whether the testis ever recovers.
What people get wrong
Often saidSperm degrades in storage, so banking years ahead is pointless
ActuallyProperly cryopreserved sperm remains viable for decades; successful ICSI pregnancies have used samples stored many years.
Often saidIf chemo wipes out the count, banked sperm cannot help
ActuallyICSI needs only one viable sperm per egg, so even small banked or low-quality samples can produce children regardless of testicular recovery.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
The people taking it
Adolescent and young-adult cancer patients (testicular cancer, lymphoma, leukemia) are the core population. Under-offering is greatest among adolescents, the acutely ill, and where systems lack a fertility-preservation referral pathway.
What we do not know
- How can referral systems ensure every reproductive-age patient is offered banking before gonadotoxic therapy?
- Why is utilization of banked sperm so low, and is that appropriate?
- What disposition and posthumous-use frameworks best fit long-stored survivor samples?
The market for this
What follows describes how this is bought and sold. It is not a buying guide and it is not an endorsement of any seller.
Initial banking plus recurring annual storage fees; later use requires IVF/ICSI costs. Insurance coverage for preservation and for later ART is inconsistent, contributing to both under-banking and non-use.
At a glance
- Storage durability
- Decades; viability not meaningfully time-limited if kept frozen
- Reproductive route
- Frozen-thawed sperm + ICSI (low counts suffice)
- Utilization
- Only a minority of banked samples are ever used
- Core gap
- Under-referral and under-offering before treatment
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Oncofertility Survivorship Outcomes. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Supply chain. We have not mapped where it is made.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
Long-term outcomes using cryopreserved sperm in cancer survivorsMultiple cohorts (e.g., van Casteren et al.; Depalo; Ferrari reviews)
Frozen-thawed sperm with ICSI achieved pregnancy/live-birth rates comparable to non-cancer frozen-sperm ICSI, even after years of storage
Utilization of banked spermCohort studies
Only a minority (often well under a quarter) of cancer survivors return to use stored sperm, though those who do have good outcomes
ASCO fertility-preservation guideline2006, updated 2013/2018
Recommends that clinicians discuss fertility preservation, including sperm banking, with all patients of reproductive age before gonadotoxic therapy